GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » 5-Year Yield-on-Cost %

Bharat Immunologicals & Biologicals (BOM:524663) 5-Year Yield-on-Cost % : 0.00 (As of May. 28, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost %?

Bharat Immunologicals & Biologicals's yield on cost for the quarter that ended in Sep. 2023 was 0.00.


The historical rank and industry rank for Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % or its related term are showing as below:



BOM:524663's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.78
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % falls into.



Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Bharat Immunologicals & Biologicals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Bharat Immunologicals & Biologicals  (BOM:524663) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Bharat Immunologicals & Biologicals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines